Corrigendum to “HMGB1 May Act via RAGE to Promote Angiogenesis in the Later Phase After Intracerebral Hemorrhage” [Neuroscience 295 (2015) 39–47](S0306452215002596)(10.1016/j.neuroscience.2015.03.032);HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage

Neuroscience

Volumn 295, Issue , 2015, Pages 39-47

  Lei, C ^a   Zhang, S ^a   Cao, T ^a   Tao, W ^a   Liu, M ^a   Wu, B ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; High mobility group box 1; Intracerebral hemorrhage; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BENZAMIDE DERIVATIVE; COLLAGENASE; ESTER; ETHYL PYRUVATE; HIGH MOBILITY GROUP B1 PROTEIN; N BENZYL 4 CHLORO N CYCLOHEXYLBENZAMIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; FPS-ZM1; GLIAL FIBRILLARY ACIDIC PROTEIN; PYRUVIC ACID DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; BRAIN HEMORRHAGE; CELL NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; UPREGULATION; VESSEL DENSITY; ANIMAL; ANTAGONISTS AND INHIBITORS; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; HEMISPHERIC DOMINANCE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; BENZAMIDES; CEREBRAL HEMORRHAGE; COLLAGENASES; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HMGB1 PROTEIN; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84926344902     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2021.11.041     Document Type: Erratum

References (31)

1. Andersson U., Erlandsson-Harris H., Yang H., Tracey K.J. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002, 72:1084-1091.
2. Biscetti F., Straface G., De Cristofaro R., Lancellotti S., Rizzo P., Arena V., Stigliano E., Pecorini G., Egashira K., De Angelis G., Ghirlanda G., Flex A. High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes 2010, 59:1496-1505.
3. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
4. Cheng P., Dai W., Wang F., Lu J., Shen M., Chen K., Li J., Zhang Y., Wang C., Yang J., Zhu R., Zhang H., Zheng Y., Guo C.Y., Xu L. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Biochem Biophys Res Commun 2014, 443:1162-1168.
5. Germani A., Limana F., Capogrossi M.C. Pivotal advances: high-mobility group box 1 protein - a cytokine with a role in cardiac repair. J Leukoc Biol 2007, 81:41-45.
6. Hayakawa K., Qiu J., Lo E.H. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci 2010, 1207:50-57.
7. Hayakawa K., Miyamoto N., Seo J.H., Pham L.D., Kim K.W., Lo E.H., Arai K. High-mobility group box 1 from reactive astrocytes enhances the accumulation of endothelial progenitor cells in damaged white matter. J Neurochem 2012, Epub ahead of print.
8. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000, 275:40096-40105.
9. Kang R., Tang D., Schapiro N.E., Loux T., Livesey K.M., Billiar T.R., Wang H., Van Houten B., Lotze M.T., Zeh H.J. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 2014, 33:567-577.
10. Kao K.K., Fink M.P. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol 2010, 80:151-159.
11. Kim J.B., Sig Choi J., Yu Y.M., Nam K., Piao C.S., Kim S.W., Lee M.H., Han P.L., Park J.S., Lee J.K. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006, 26:6413-6421.
12. Krum J.M., Mani N., Rosenstein J.M. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp Neurol 2008, 212:108-117.
13. Lee Y.M., Kim J., Jo K., Shin S.D., Kim C.S., Sohn E.J., Kim S.G., Kim J.S. Ethyl pyruvate inhibits retinal pathogenic neovascularization by downregulating HMGB1 expression. J Diabetes Res 2013, 2013:245271.
14. Lei C., Lin S., Zhang C., Tao W., Dong W., Hao Z., Liu M., Wu B. Effects of high-mobility group box1 on cerebral angiogenesis and neurogenesis after intracerebral hemorrhage. Neuroscience 2013, 229:12-19.
15. Lei C., Lin S., Zhang C., Tao W., Dong W., Hao Z., Liu M., Wu B. High-mobility Group Box1 protein promotes neuroinflammation after intracerebral hemorrhage in rats. Neuroscience 2013, 228:190-199.
16. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., Leoni O., Palumbo R., Battistini L., Rastaldo R., Müller S., Pompilio G., Anversa P., Bianchi M.E., Capogrossi M.C. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 2005, 97:e73-e83.
17. Liu M., Wu B., Wang W.Z., Lee L.M., Zhang S.H., Kong L.Z. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007, 6:456-464.
18. Luan Z.G., Zhang J., Yin X.H., Ma X.C., Guo R.X. Ethyl pyruvate significantly inhibits tumour necrosis factor-α, interleukin-1β and high mobility group box 1 releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury. Clin Exp Immunol 2013, 172:417-426.
19. Navaratna D., Guo S., Arai K., Lo E.H. Mechanisms and targets for angiogenic therapy after stroke. Cell Adh Migr 2009, 3:216-223.
20. Qiu J., Nishimura M., Wang Y., Sims J.R., Qiu S., Savitz S.I., Salomone S., Moskowitz M.A. Early release of HMGB1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008, 28:927-938.
21. Qureshi A.I., Mendelow A.D., Hanley D.F. Intracerebral haemorrhage. Lancet 2009, 373:1632-1644.
22. Schlueter C., Weber H., Meyer B., Rogalla P., Roser K., Hauke S., Bullerdiek J. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am J Pathol 2005, 166:1259-1263.
23. Shang J., Deguchi K., Ohta Y., Liu N., Zhang X., Tian F., Yamashita T., Ikeda Y., Matsuura T., Funakoshi H., Nakamura T., Abe K. Strong neurogenesis, angiogenesis, synaptogenesis, and antifibrosis of hepatocyte growth factor in rats brain after transient middle cerebral artery occlusion. J Neurosci Res 2011, 89:86-95.
24. Shimotake J., Derugin N., Wendland M., Vexler Z.S., Ferriero D.M. Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 2010, 41:343-349.
25. Su X., Wang H., Zhao J., Pan H., Mao L. Beneficial effects of ethyl pyruvate through inhibiting high-mobility group Box 1 expression and TLR4/NF-κB pathway after traumatic brain injury in the rat. Mediators Inflamm 2011, 2011:807142.
26. Teng H., Zhang Z.G., Wang L., Zhang R.L., ZhangL Morris D., Gregg S.R., Wu Z., Jiang A., Lu M., Zlokovic B.V., Chopp M. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab 2008, 28:764-771.
27. van Beijnum J.R., Nowak-Sliwinska P., van den Boezem E., Hautvast P., Buurman W.A., Griffioen A.W. Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene 2013, 32:363-374.
28. Wang H., Ward M.F., Sama A.E. Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets 2014, 18:257-268.
29. Xiong Y., Mahmood A., Chopp M. Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs 2011, 11:298-308.
30. Ye C., Choi J.G., Abraham S., Wu H., Diaz D., Terreros D., Shankar P., Manjunath N. Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc Natl Acad Sci U S A 2012, 109:21052-21057.
31. Zurolo E., Iyer A., Maroso M., Carbonell C., Anink J.J., Ravizza T., Fluiter K., Spliet W.G., van Rijen P.C., Vezzani A., Aronica E. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. Brain 2011, 134:1015-1032.